Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Pharmaron financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.

Stock Price

¥30

2024-10-29

Market Capitalization

¥48.1 B

2024-10-29

Revenue

¥11.5 B

FY, 2023

CreditSafe Score

?
Score changed on Jan 18, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue2.9B3.7B5.1B7.4B10.2B11.5B
Cost of goods sold2.0B2.4B3.2B4.8B6.5B7.4B
Gross profit924.8M1.3B1.9B2.6B3.7B4.0B
Gross profit margin, %32.3%35.2%37.2%35.7%36.4%35.3%
Operating expense total265.4M359.7M522.4M839.0M1.4B1.5B
Depreciation and amortization214.3M265.8M304.0M407.8M564.3M764.5M
EBITDA658.3M936.1M1.3B1.9B2.3B2.5B
EBITDA margin, %23.0%25.3%26.4%25.3%22.2%21.8%
EBIT447.7M723.4M1.2B1.6B1.8B1.8B
EBIT margin, %15.6%19.5%24.5%22.1%17.4%15.7%
Interest income368.0K9.6M74.1M64.4M35.2M33.5M
Interest expense82.4M82.5M23.9M83.1M167.3M182.2M
Pre tax profit392.6M632.6M1.3B1.9B1.7B1.8B
Income tax expense59.7M101.9M172.4M290.9M314.3M256.1M
Net Income332.8M530.7M1.1B1.6B1.4B1.6B

Acquisitions & Subsidiaries

Company nameDateDeal size
LoremDec 23, 2021$40.0M
IpsumJan 18, 2022$30.0M
Lorem IpsumFeb 18, 2022$25.0M
DolorOct 21, 2021$60.0M
Premium Content only available in Craft’s Intelligence Portal
View acquisitions and subsidiaries by company, date, and deal size.
Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm.
Learn more

Footer menu